Inogen named a top 2019 smid-cap pick at JPMorgan. JPMorgan analyst Robbie Marcus names Inogen a top smid-cap pick for 2019 and keeps an Overweight rating on the shares. He views current shares levels as a “highly attractive entry point.” The company is potentially on the “verge of a multi-year growth story and a history of consistent beats and raises,” Marcus tells investors in a research note. The analyst lowered his price target for Inogen to $200 from $240.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.